Your account is not claimed yet. You can sign up with ORCID to claim your account.

Dávid Szüts (D Szüts, David Szuts)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Venues

BMC bioinformatics

The EMBO journal

Proceedings of the National Academy of Sciences of the United States of America

Genome biology

Research Centre for Natural Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Research Centre for Natural Sciences

Hungary

Principal Intestigator :: Institute of Enzymology

Publications

Evelyn Incze, Katalin Mangó, Ferenc Fekete, Ádám Ferenc Kiss, Ádám Póti, Tünde Harkó, Judit Moldvay, Dávid Szüts, Katalin Monostory
Potential Association of Cytochrome P450 Copy Number Alteration in Tumour with Chemotherapy Resistance in Lung Adenocarcinoma Patients. International journal of molecular sciences 24 (17) (2023)
Rita Lózsa, Eszter Németh, Judit Z Gervai, Bence Gábor Márkus, Sándor Kollarics, Zsolt Gyüre, Judit Tóth, Ferenc Simon, Dávid Szüts
DNA mismatch repair protects the genome from oxygen-induced replicative mutagenesis. Nucleic acids research (2023)
Ádám Póti, Bernadett Szikriszt, Judit Zsuzsanna Gervai, Dan Chen, Dávid Szüts
Characterisation of the spectrum and genetic dependence of collateral mutations induced by translesion DNA synthesis. PLoS genetics 18 (2) (2022)
Dan Chen, Judit Z Gervai, Ádám Póti, Eszter Németh, Zoltán Szeltner, Bernadett Szikriszt, Zsolt Gyüre, Judit Zámborszky, Marta Ceccon, Fabrizio d'Adda di Fagagna, Zoltan Szallasi, Andrea L Richardson, Dávid Szüts
BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1. Nature communications 13 (1) (2022)
Zoltán Szeltner, Ádám Póti, Gábor M Harami, Mihály Kovács, Dávid Szüts
Evaluation and modulation of DNA lesion bypass in an SV40 large T antigen-based in vitro replication system. FEBS open bio 11 (4) (2021)
Ye He, Joshua Rivera, Miklos Diossy, Haohui Duan, Christian Bowman-Colin, Rachel Reed, Rebecca Jennings, Jesse Novak, Stevenson V Tran, Elizabeth F Cohen, Dávid Szüts, Anita Giobbie-Hurder, Roderick T Bronson, Adam J Bass, Sabina Signoretti, Zoltan Szallasi, David M Livingston, Shailja Pathania
BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model. Proceedings of the National Academy of Sciences of the United States of America 118 (41) (2021)
Miklos Diossy, Zsofia Sztupinszki, Judit Börcsök, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger, Judit Moldvay, Anders Gorm Pedersen, Dávid Szüts, Zoltan Szallasi
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures. NPJ precision oncology 5 (1) (2021)
Mattia Pavani, Paolo Bonaiuti, Elena Chiroli, Fridolin Gross, Federica Natali, Francesca Macaluso, Ádám Póti, Sebastiano Pasqualato, Zoltán Farkas, Simone Pompei, Marco Cosentino Lagomarsino, Giulia Rancati, Dávid Szüts, Andrea Ciliberto
Epistasis, aneuploidy, and functional mutations underlie evolution of resistance to induced microtubule depolymerization. The EMBO journal 40 (22) (2021)
Ádám Póti, Hella Gyergyák, Eszter Németh, Orsolya Rusz, Szilárd Tóth, Csenger Kovácsházi, Dan Chen, Bernadett Szikriszt, Sándor Spisák, Shunichi Takeda, Gergely Szakács, Zoltan Szallasi, Andrea L Richardson, Dávid Szüts
Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents. Genome biology 20 (1) (2019)
Eszter Németh, Marcin Krzystanek, Lilla Reiniger, Dezső Ribli, Orsolya Pipek, Zsófia Sztupinszki, Tibor Glasz, István Csabai, Judit Moldvay, Zoltan Szallasi, Dávid Szüts
The genomic imprint of cancer therapies helps timing the formation of metastases. International journal of cancer 145 (3) (2019)
Ádám Póti, Kinga Berta, Yonghong Xiao, Orsolya Pipek, Gregory T Klus, Thomas Ried, István Csabai, Keith Wilcoxen, Keith Mikule, Zoltan Szallasi, Dávid Szüts
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts. British journal of cancer 119 (11) (2018)
O Pipek, D Ribli, J Molnár, Á Póti, M Krzystanek, A Bodor, G E Tusnády, Z Szallasi, I Csabai, Dávid Szüts
Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut. BMC bioinformatics 18 (1) (2017)

Dávid Szüts.css-eqlu8i{font-size:small;padding-left:4px;} (D Szüts, David Szuts)

Publication Activity (10 Years)

Top Topics

Top Venues

Dávid Szüts (D Szüts, David Szuts)